– Milestone reflects Eli Lilly and Company’s commitment to bring new diagnostic tool to physicians evaluating patients’ cognitive decline

INDIANAPOLIS, Oct. 19, 2012 /PRNewswire — Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today

Read More